The Relationship between MMP 2,MMP 9 Expression and Clinic Pathological Features in Non-small-cell Lung Carcinoma

( views:, downloads: )
Author:
Tian Dong-bo()
HU Guo-hong()
XIAO Wei-min()
()
()
()
Journal Title:
JOURNAL OF MODERN CLINICAL MEDICAL BIOENGINEERING
Issue:
Volume 11, Issue 03, 2005
DOI:
Key Word:

Abstract´╝Ü

  • [1]Parson SL,Waston SA,Brown PD,et al.Matrix metalloproteinases[J].Br J Surg,1997,84:160.
  • [2]Ginberg RJ,Kris MG,Armstrong JG.Cancer of the lung.In:Devita VT,Hellmans,Rosenberg SA,eds. Cancer Principles and Practice of Oncology[M].Philadelphia:Lippincott,1993,673.
  • [3]Mareel MM,Van Roy FM,Bracke ME. How and when do tumor cells metastsize[J]. Criticial Reviews in Oncogenesis,1993,4:559.
  • [4]Konttinen YT,Ainola M,Valleala H,et al. Analysis of 16 different matrix metalloproteinases(MMP1 to MMP 20)in the synovial membrane:different profiles in trauma and rheumatoid arthritis[J].Ann Rheum Dis,1999,58:691.
  • [5]Ozenci V,Rinaldi L,Teleshova N,et al. Metalloproteinases and their tissue inhibitor in multiple sclerosis[J].Jautoimmun,1999,12:297.
  • [6]Farias E,Ranuncolo S,Cresta C,et al. Plasma metalloproteinases activity is enhanced in the eugbulin fraction of breast and lung cancer patient[J].Int J Cancer,2000,89:389.
  • [7]Suzuki M,Iizasa T,Fujisawa T,et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in non-small-cell lung cancer.Invasion[J]. Invasion & Metastasis,1998,18:134.
  • [8]Nawrocki B,Polette M,Marchand V,et al. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas:Quantificative and morphological analyses[J]. Int J Cancer,1997,72:556.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn